Microbot Medical Inc.
Microbot Medical Inc. (MBOT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mbot · stock forecast · 3 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Buy
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$4.00
Consensus
$4.00
+119.8% upside
Low
$4.00
Median: $4 · Last Close: $1.82
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.83 | ↑ 0.77% |
1-day model range: $1.81–$1.85. Peak: $1.85 (+0.77%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $1 | -62.5% |
| 2029 | $1 | -67.2% |
| 2030 | $1 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MBOT · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-04-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-10-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-06-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Microbot Medical Inc. (MBOT) stock. Of the recent 24 rating actions, 0 were upgrades and 2 were downgrades. 3 analysts currently cover MBOT.
Analyst Recommendation Trends
MBOT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 98.9% YoY
Revenue Next Year
$5M
↑ 3929.4% YoY
EPS This Year
$-0.30
EPS Next Year
$-0.29
↓ 4.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast MBOT EPS of $-0.30 for the current fiscal year, based on estimates from 3 analysts. The MBOT revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MBOT stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MBOT price target is $4.00 (+119.8% upside), with an analyst consensus of Buy.
The MBOT short-term stock prediction for tomorrow is $1.83 (+0.77%). The MBOT stock price prediction for 2027 estimates an average of $1. The MBOT stock prediction for 2030 projects a range of $1–$1.
Microbot Medical Inc. trades on NASDAQ under the ticker MBOT. The MBOT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
MBOT forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month MBOT price target is $4.00, with a high forecast of $4.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +119.8% potential upside from the current price of $1.82.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.